| Market Cap | 56.90M |
| Revenue (ttm) | 226.97M |
| Net Income (ttm) | -6.27M |
| Shares Out | 21.00M |
| EPS (ttm) | -0.30 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 90,233 |
| Open | 2.800 |
| Previous Close | 2.750 |
| Day's Range | 2.700 - 2.900 |
| 52-Week Range | 2.420 - 6.850 |
| Beta | 0.74 |
| Analysts | Sell |
| Price Target | 3.20 (+18.08%) |
| Earnings Date | Oct 14, 2025 |
About PETS
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthri... [Read more]
Financial Performance
In 2024, PetMed Express's revenue was $226.97 million, a decrease of -17.19% compared to the previous year's $274.10 million. Losses were -$6.27 million, -15.98% less than in 2023.
Financial StatementsAnalyst Summary
According to one analyst, the rating for PETS stock is "Sell" and the 12-month stock price target is $3.2.
News
PetMed Express, Inc. Appoints Former Deloitte Partner James LaCamp as Director and Audit Committee Chair
Seasoned corporate director brings extensive expertise in audit, accounting, and internal controls Fourth independent director to join the board since 2024 DELRAY BEACH, Fla., Oct. 20, 2025 (GLOBE NEW...
PETMED REMINDER: Bragar Eagel & Squire, P.C. Reminds PetMed Express Investors of the Ongoing Investigation on Behalf of Stockholders
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In PetMed (PETS) To Contact Him Directly To Discuss Their Options If you purchased or acquired...
PetMeds® Files Form 10-K for Fiscal 2025
DELRAY BEACH, Fla., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today filed with the Securities and Exchange Commi...
PetMed Express (PETS) Faces Investor Scrutiny Amid Filing Delays, Executive Departures, Admitted Accounting Rule Violations -- Hagens Berman
SAN FRANCISCO, Oct. 13, 2025 (GLOBE NEWSWIRE) -- Investors in PetMed Express (NASDAQ: PETS) have seen the price of their shares steadily decline by about 26% since June 16, 2025, when the company anno...
PetMed Express, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DELRAY BEACH, Fla., Oct. 08, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS), today announced that on September 9, 2025, the Co...
PetMed Express, Inc. Investors: Company Investigated by the Portnoy Law Firm
Investors can contact the law firm at no cost to learn more about recovering their losses
PetMed Express, Inc. Announces Management Changes
DELRAY BEACH, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced that its Chief Executive Officer, ...
PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
DELRAY BEACH, Fla., July 03, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (“PetMeds®”) (NASDAQ: PETS) received on July 2, 2025, an expected notice (the “Notice”) from The Nasdaq Stock Market LLC (“Na...
PetMed Express, Inc. Provides Update on Status of Fourth Quarter and FY 2025 Results and Form 10-K Filing
DELRAY BEACH, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today provided an update on the status of its four...
PetMed Express, Inc. Announces Preliminary Fourth Quarter and FY 2025 Results and Filing of Form 12b-25
DELRAY BEACH, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced preliminary fourth quarter and fiscal year 2025 re...
PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call
DELRAY BEACH, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced it is delaying the release of the Company's fourth...
PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call
DELRAY BEACH, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) will hold a conference call on Tuesday, June 10, 2025 at 4:30pm E...
PetMed Express, Inc. and Dutch Announce Partnership to Provide Accessible Telehealth Services for Pets
Strategic Collaboration Marks PetMeds' Latest Move in Expanding Its Pet Healthcare Ecosystem Strategic Collaboration Marks PetMeds' Latest Move in Expanding Its Pet Healthcare Ecosystem
PetMeds® to Ring Nasdaq Opening Bell in Celebration of National Pet Day on April 11th
DELRAY BEACH, Fla., April 11, 2025 (GLOBE NEWSWIRE) -- In celebration of National Pet Day, PetMed Express, Inc. (NASDAQ: PETS)—the original consumer pet healthcare company serving dogs, cats, and hors...
PetMed Express, Inc. Announces Appointment of Peter Batushansky to Board of Directors
Former pet industry executive with more than 20 years of experience across retail, pet, healthcare, and private equity Third independent director to join the Board since 2024 Longtime board member and...
PetMed Express, Inc. (PETS) Q3 2025 Earnings Call Transcript
PetMed Express, Inc. (NASDAQ:PETS) Q3 2025 Earnings Conference Call February 10, 2025 4:30 PM ET Company Participants Reed Anderson - IR, ICR Sandra Campos - CEO and President Robyn D'Elia - CFO Conf...
PetMed Express: Dip Or Rip, A Buy After Earnings
PetMed Express stock could surge or sink after this week's quarterly earnings release, but don't read too much into this near-term event. A disappointing earnings release won't necessarily shatter the...
PetMeds® Adopts Limited Duration Shareholder Rights Plan
DELRAY BEACH, Fla., Dec. 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) (“PetMeds” or the “Company”), today announced that its Board of Di...
PetMeds Migrates to Ordergroove as its New Subscription and Membership Technology Partner
NEW YORK--(BUSINESS WIRE)--Ordergroove, the leading technology platform that powers subscriptions for top brands and retailers, today announced a strategic partnership with PetMed Express, Inc. (NASDA...
PetMed Express: Why (And Why Not) The Rebound Could Continue
PetMed Express (PETS) surged 35.8% on Nov. 7, following the online pet pharmacy's latest quarterly earnings release. Despite the massive post-earnings surge, further upside may lie ahead, if the turna...
PetMed Express, Inc. (PETS) Q2 2025 Earnings Call Transcript
PetMed Express, Inc. (PETS) Q2 2025 Earnings Call Transcript
PetMeds® Announces Second Quarter Fiscal 2025 Financial Results
DELRAY BEACH, Fla., Nov. 06, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its second quarter ended...
PetMed Express, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
DELRAY BEACH, Fla., Aug. 21, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS), will participate in the Morgan Stanley 22nd Annual Global Healt...
PetMed Express, Inc. (PETS) Q1 2025 Earnings Call Transcript
PetMed Express, Inc. (NASDAQ:PETS) Q1 2025 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Reed Anderson - Investor Relations, ICR Sandra Campos - Chief Executive Officer & Pr...
PetMed Express, Inc. Announces Appointment of Doug Krulik as Chief Accounting Officer
Krulik Brings More than 20 Years of Leadership Experience in Finance and Accounting Krulik Brings More than 20 Years of Leadership Experience in Finance and Accounting